https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-riseContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u18911Tue, 30 Jun 2026 14:02:06 +0000Synthetic GLP-1 medications like semaglutide are used to treat diabetes and obesity by mimicking natural hormones. A study of over 600,000 U.S. veterans indicates these drugs may lower the risk of substance use disorders. However, some patients report severe reactions after obtaining medications via telehealth.What's confirmed:GLP-1 agonists are FDA-approved for treating diabetes and obesity.These medications reduce appetite and slow the rate at which food leaves the stomach.Still unconfirmed:Karleigh McClain was hospitalized within 24 hours of injecting a weight loss medication from a telehea https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u13465Thu, 25 Jun 2026 23:17:11 +0000Overdoses and misuse of GLP-1 medications are rising. Experts attribute this spike to people using unregulated telehealth shortcuts to obtain weight loss drugs without doctors.What's confirmed:Overdoses and misuse of GLP-1 medications are increasing.Still unconfirmed:People are bypassing doctors and using unregulated telehealth shortcuts to access weight loss medication.Generation Z is using GLP-1 drugs to pursue skinny culture extremes. https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u9063Tue, 23 Jun 2026 01:01:41 +0000The FDA has issued 25 warning letters to telehealth companies regarding misleading claims about compounded weight loss and diabetes drugs. Novo Nordisk and Eli Lilly are both seeking an FDA ban on these cheaper compounded versions. These drugs work by mimicking the glucagon-like peptide 1 hormone to slow digestion and increase insulin.What's confirmed:The US FDA sent 25 warning letters to telehealth companies for making misleading claims about compounded weight loss and diabetes drugs.Novo Nordisk and Eli Lilly have asked the FDA to ban compounding pharmacies from producing cheaper versions of https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u5094Fri, 19 Jun 2026 21:56:08 +0000Life-threatening overdoses from GLP-1 drugs are increasing. This trend is driven by telehealth access, dosing errors, and drug misuse. Poison control data shows a rise in these cases since 2021.Still unconfirmed:GLP-1 receptor agonists like semaglutide and tirzepatide have created a multibillion-dollar industry bridging pharmaceuticals and digital.Medications such as Ozempic and Wegovy may reduce impulsive and violent behaviors.GLP-1 drugs may offer mental health benefits beyond treating addiction and alcohol use. https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u3347Thu, 18 Jun 2026 14:22:31 +0000Life-threatening overdoses linked to GLP-1 weight-loss drugs are increasing due to telehealth accessibility, compounded drug misuse, and preventable dosing mistakes. The crisis demands urgent attention as poison control reports show a rising trend since 2021. Experts stress the need for awareness and safe dosing practices.What's confirmed:GLP-1 overdoses are on the rise, with a troubling uptick in cases reported by poison control centers since 2021.The surge in injectable weight loss medications has coincided with an increase in GLP-1 overdoses.Patients are becoming violently ill after misusin https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u3030Thu, 18 Jun 2026 06:21:10 +0000Life-threatening overdoses linked to GLP-1 weight-loss drugs are accelerating due to telehealth accessibility, compounded drug misuse, and preventable dosing mistakes. The FDA has already flagged multiple manufacturers for violations, while poison control reports show a rising trend since 2021. A new study suggests potential unintended benefits—such as reduced violence—but experts stress the growing overdose crisis demands urgent attention. Retail availability of discounted GLP-1 medications may further complicate risks.What's confirmed:Life-threatening overdoses tied to GLP-1 weight-loss drug https://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-risehttps://www.live-feeds.com/feed/life-threatening-glp-1-overdoses-are-on-the-rise#u2726Thu, 18 Jun 2026 01:27:31 +0000Life-threatening overdoses linked to GLP-1 weight-loss drugs are rising sharply, driven by telehealth accessibility, compounded drug misuse, and preventable dosing errors. The FDA has cited multiple companies for violations, including illegal marketing and manufacturing lapses. Symptoms range from severe vomiting to seizures, with poison control calls increasing since 2021. Experts warn of growing risks as demand outpaces regulated distribution.What's confirmed:The FDA has sent 25 warning letters to telehealth companies for illegally marketing or promoting compounded GLP-1 weight-loss drugs.Te